FDA Investigator Marisol Faberlle
Marisol Faberlle has inspections in 2 countries as of 05 Sep 2022. Marisol Faberlle has collaborated with a combinined 1073 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
8
Last Inspection Date:
05 Sep 2022
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Netherlands
Co-Investigator(s):
An T Vu,
Anthony A Charity,
Arlene M Badillo,
Barbara Janine Breithaupt,
Bonita S Chester,
Brian R Yaun,
Brooke K Higgins,
CDR Ileana Barreto Pettit,
Dayna I Martinez,
Dennis Cantellops Paite,
Douglas A Campbell,
Elena Karnaukhova, PhD,
Farhana Khan,
Frances L Dejesus,
Frank W Perrella,
Gerardo Z Vazquez,
Hanisol Fabenelle,
Iraida Ortiz,
Jaime E Pares,
James D Planchon,
James P Mcreavey,
Javier O Vega,
Jensel L Guadalupe,
Joan M Cantellops Figueroa,
Jorge L Guadalupe,
Jose Acruz Gonzalez,
Jose I Guadalupe,
Jose R Lopez,
Jose Velez,
Kham Phommachanh,
Kimberley A Hoefen,
Libia M Lugo,
Luis M Burgos Medero,
Marian E Ramirez,
Marianela Aponte Cruz,
Maridalia Torres Irizarry,
Marisal Faberhe,
Marvin D Jones,
Meisha R Sampson,
Meisha Waters,
Myriam M Sosa,
Nicole K Trudel,
Noreen Muniz,
Patrick L Wisor,
Paul L Figarole, Jr,
Reyes Candau Chacon, PhD,
Richard Heath Coats,
Robert J Ham,
State Agency,
Steven C Madzo,
Steven M Weinman,
Susant Hadman,
Tara G Bizjak,
Tara R Gooen,
Terri L Dodds,
Tiffani D Wilson,
Truong Xuan Nguyen (Andy),
Wayne T Smith,
Yumi J Hiramine
Marisol Faberlle's Documents
Publish Date | Document Type | Title |
---|---|---|
October, 2000 | EIR | Merck Sharp & Dohme BV - EIR, 2000-10-25 |
October, 2000 | FDA 483 Response | N.v. Organon - Form 483R, 2000-12-12 |
November, 2000 | FDA 483 Response | Avebe - Form 483R, 2000-11-23 |
October, 2000 | FDA 483 Response | Merck Sharp & Dohme BV - Form 483R, 2000-11-06 |
November, 2000 | FDA 483 | Glucona B.V. - Form 483, 2000-11-01 |
October, 2003 | FDA 483 | Janssen Ortho LLC - Form 483, 2003-10-15 |
October, 2003 | EIR | Janssen Ortho LLC - EIR, 2003-10-15 |
October, 2000 | EIR | N.v. Organon - EIR, 2000-10-20 |
November, 2000 | EIR | Avebe - EIR, 2000-11-01 |
October, 2000 | FDA 483 | Merck Sharp & Dohme BV - Form 483, 2000-10-25 |
October, 2000 | FDA 483 | MSD Organon - Form 483, 2000-10-18 |
October, 2003 | FDA 483 Response | Janssen Ortho LLC - Form 483R, 2003-12-19 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more